PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness Life Science Investing
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+ in Preclinical Cancer Models Biotech Investing
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026 Life Science Investing
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis Life Science Investing
Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 Life Science Investing
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 Life Science Investing
Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
